Immune Design Corp.·4

Jan 6, 7:25 PM ET

Immune Design Corp. 4

4 · Immune Design Corp. · Filed Jan 6, 2016

Insider Transaction Report

Form 4
Period: 2016-01-04
PENHOET EDWARD
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2016-01-04+9,3009,300 total
    Exercise: $19.39Exp: 2026-01-04Common Stock (9,300 underlying)
Footnotes (1)
  • [F1]The shares underlying the option will become fully vested on January 4, 2017, subject to the Reporting Person's continuous service through such date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT